Recombinant CD52 (Alemtuzumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CD52 (Alemtuzumab Biosimilar) products
- CD52 (Alemtuzumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CD52 (Alemtuzumab Biosimilar) antibody is un-conjugated
- Application
- ELISA
- Purpose
- Alemtuzumab Biosimilar - Anti-CD52 mAb
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CD52 (Alemtuzumab Biosimilar)
- Abstract
- CD52 (Alemtuzumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
Campath-1H,LDP-03
Alemtuzumab is a recombinant humanized monoclonal antibody (Campath-1H), which targets the 21-28 kD cell surface glycoprotein CD52. The Campath-1H antibody is of isotype IgG1, with human variable framework and constant regions, and a complementarity determining region derived from a murine (rat) monoclonal antibody (Campath-1G). - CAS-No
- 216503-57-0
-
You are here:
